Efficacy and safety of semaglutide in subjects with type 2 diabetes by race and ethnicity: a post hoc analysis of the SUSTAIN trials

被引：0
|
作者：
Desouza, C. [1 ]
Garg, S. [2 ]
Cariou, B. [3 ]
Furberg, J. K. [4 ]
Navarria, A. [4 ]
Nayak, G. [4 ]
Fonseca, V. [5 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE USA
[2] Univ Colorado Denver, Barbara Davis Ctr Diabet, Denver, CO 80202 USA
[3] CHU Nantes, Inst Thorax, Dept Endocrinol, Nantes, France
[4] Novo Nordisk AS, Soborg, Denmark
[5] Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70118 USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
755
引用
收藏
页码：S369 / S370
页数：2
相关论文
共 50 条
  • [1] Efficacy and Safety of Semaglutide for Type 2 Diabetes by Race and Ethnicity: A Post Hoc Analysis of the SUSTAIN Trials
    DeSouza, Cyrus
    Cariou, Bertrand
    Garg, Satish
    Lausvig, Nanna
    Navarria, Andrea
    Fonseca, Vivian
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (02): : 543 - 556
  • [2] Efficacy and safety of semaglutide in elderly subjects with type 2 diabetes: a post hoc analysis of the SUSTAIN 7 trial
    Aroda, V. R.
    Sugimoto, D.
    Trachtenbarg, D.
    Warren, M.
    Navarria, A.
    Nayak, G.
    Nielsen, M. Abildlund
    Woo, V.
    [J]. DIABETOLOGIA, 2018, 61 : S367 - S367
  • [3] Efficacy and safety of once-weekly semaglutide in elderly subjects with type 2 diabetes: post hoc analysis of SUSTAIN 1-5 trials
    Warren, M.
    Chaykin, L.
    Trachtenbarg, D.
    Nayak, G.
    Wijayasinghe, N.
    Cariou, B.
    [J]. DIABETOLOGIA, 2017, 60 : S378 - S379
  • [4] Efficacy and safety of semaglutide 2.4 mg by race and ethnicity: A post hoc analysis of three randomized controlled trials
    Rubino, Domenica
    Angelene, Hanna
    Fabricatore, Anthony
    Ard, Jamy
    [J]. OBESITY, 2024, 32 (07) : 1268 - 1280
  • [5] Efficacy and safety of once-weekly semaglutide in Japanese individuals with type 2 diabetes in the SUSTAIN 1, 2, 5 and 9 trials: Post-hoc analysis
    Araki, Eiichi
    Harashima, Shinichi
    Nishida, Tomoyuki
    Nakamura, Jiro
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2022, : 1971 - 1980
  • [6] IMPACT OF RACE/ETHNICITY ON THE EFFICACY AND SAFETY OF COMMONLY USED INSULIN REGIMENS: A POST HOC ANALYSIS OF CLINICAL TRIALS IN TYPE 2 DIABETES MELLITUS
    Davidson, Jaime A.
    Lacaya, Lyndon B.
    Jiang, Honghua
    Heilmann, Cory R.
    Scism-Bacon, Jamie L.
    Gates, Jeffrey R.
    Jackson, Jeffrey A.
    [J]. ENDOCRINE PRACTICE, 2010, 16 (05) : 818 - 828
  • [7] Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials
    Verma, Subodh
    Bain, Stephen C.
    Fries, Tea Monk
    Mazer, C. David
    Nauck, Michael A.
    Pratley, Richard E.
    Rasmussen, Soren
    Saevereid, Hans A.
    Zinman, Bernard
    Buse, John B.
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (07): : 1745 - 1751
  • [8] SUSTAIN 6: A POST-HOC ANALYSIS OF THE EFFECT OF SEMAGLUTIDE ON CARDIOVASCULAR OUTCOMES OVER TIME IN SUBJECTS WITH TYPE 2 DIABETES
    Bellary, S.
    Jodar, E.
    Seufert, J.
    Damgaard, L. H.
    Holst, A. Gaarsdal
    Leiter, L.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2018, 34 : E6 - E7
  • [9] Effect of once-weekly semaglutide on insulin use in subjects with type 2 diabetes: a post hoc analysis of SUSTAIN 6
    Seufert, J.
    Desouza, C.
    Kirk, A. R.
    Lawson, J.
    Lingvay, I.
    Sondergaard, A. L.
    Bain, S. C.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 251 - 252
  • [10] SUSTAIN 6: a post-hoc analysis of the effect of semaglutide on cardiovascular outcomes over time in subjects with type 2 diabetes
    Jodar, E.
    Seufert, J.
    Damgaard, L. H.
    Holst, A. G.
    Leiter, L. A.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 : 819 - 819
12345